COCP
Price:
$0.9949
Market Cap:
$10.20M
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses. Its current pipeline includes CC-31244, a non-nucleoside polymerase inhibitor for HCV, which has successfully completed Phase IIa clinical trials. Additionally, CC-42344, a PB2 inhibitor designed to combat influenza, is currently undergoing preclinical development. Cocrystal Pharma is also actively pursuing the development of non-nucle...[Read more]
Industry
Biotechnology
IPO Date
2012-02-22
Stock Exchange
NASDAQ
Ticker
COCP
According to Cocrystal Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.38. This represents a change of -10.59% compared to the average of -1.54 of the last 4 quarters.
The mean historical PE Ratio of Cocrystal Pharma, Inc. over the last ten years is -25.84. The current -1.38 PE Ratio has changed 434.14% with respect to the historical average. Over the past ten years (40 quarters), COCP's PE Ratio was at its highest in in the December 2017 quarter at 7.04. The PE Ratio was at its lowest in in the September 2016 quarter at -46.07.
Average
-25.84
Median
-1.65
Minimum
-236.14
Maximum
-0.38
Discovering the peaks and valleys of Cocrystal Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.32%
Maximum Annual PE Ratio = -0.38
Minimum Annual Increase = -99.13%
Minimum Annual PE Ratio = -236.14
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.25 | 6.60% |
| 2024 | -1.17 | 27.20% |
| 2023 | -0.92 | 125.76% |
| 2022 | -0.41 | -90.33% |
| 2021 | -4.23 | -47.89% |
| 2020 | -8.11 | 2.03% |
| 2019 | -0.38 | -81.50% |
| 2018 | -2.06 | -99.13% |
| 2017 | -236.14 | 6.32% |
| 2016 | -3.68 | -67.17% |
The current PE Ratio of Cocrystal Pharma, Inc. (COCP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.12
5-year avg
-1.60
10-year avg
-25.84
Cocrystal Pharma, Inc.’s PE Ratio is less than Evogene Ltd. (-0.47), less than Imunon, Inc. (-0.69), less than Sensei Biotherapeutics, Inc. (-0.09), greater than Marker Therapeutics, Inc. (-2.45), less than Traws Pharma, Inc. (-0.94), less than BioRestorative Therapies, Inc. (-0.29), greater than Dogwood Therapeutics, Inc. (-1.82), less than Bolt Biotherapeutics, Inc. (-0.29), greater than Immuron Limited (-2.01), less than Cingulate Inc. (-0.96),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.47 | $5.03M | |
| -0.69 | $5.09M | |
| -0.09 | $17.45M | |
| -2.45 | $14.90M | |
| -0.94 | $11.70M | |
| -0.29 | $3.17M | |
| -1.82 | $2.94M | |
| -0.29 | $8.76M | |
| -2.01 | $7.67M | |
| -0.96 | $27.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cocrystal Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cocrystal Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cocrystal Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cocrystal Pharma, Inc. (COCP)?
What is the highest PE Ratio for Cocrystal Pharma, Inc. (COCP)?
What is the 3-year average PE Ratio for Cocrystal Pharma, Inc. (COCP)?
What is the 5-year average PE Ratio for Cocrystal Pharma, Inc. (COCP)?
How does the current PE Ratio for Cocrystal Pharma, Inc. (COCP) compare to its historical average?